Epiomic Epidemiology Series: Norovirus Forecast for selected Asian Markets 2017-2027

Epiomic Epidemiology Series: Norovirus Forecast for selected Asian Markets 2017-2027

  • January 2017 •
  • 40 pages •
  • Report ID: 4672238 •
  • Format: PDF
Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Norovirus in Selected Asian Markets

Norovirus, also known as Norwalk virus or Norwalk-like viruses (NLV), are a group of non-enveloped, single-stranded RNA viruses that cause acute gastroenteritis. Noroviruses belong to the family Caliciviridae which includes sapoviruses, which also cause acute gastroenteritis.

Currently, there are six recognized norovirus genogroups, three of which (GI, GII, and GIV) affect humans. More than 25 different genotypes have been identified within these three genogroups. Variants of the GII.4 genotype are the most common cause of norovirus outbreaks.

This report provides the current incident population for Norovirus across Selected Asian Markets (Cambodia, Indonesia, Lao PDR and Viet Nam) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms of Norovirus have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Signs and symptoms of norovirus infection include:
• Nausea
• Vomiting
• Abdominal pain or cramps
• Watery or loose diarrhoea
• Malaise
• Low-grade fever
• Muscle pain

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy
• Able to quantify patient populations in global Norovirus’s market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the incidence of the subdivided types of Norovirus and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Identify sub-populations within Norovirus which require treatment.
• Gain an understanding of the specific markets that have the largest number of Norovirus patients.

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.